JUN 27, 2018 7:06 AM PDT

Cannabis-Based Therapy Drug For The Treatment of Epilepsy

WRITTEN BY: Nouran Amin

A drug derived from marijuana has been the first to be approved by the U.S. Food and Drug Administration for the treatment epilepsy.

The drug, which will be marketed under the name Epidiolex, will specifically seek to treat two serious forms of epilepsy: Lennox-Gastaut syndrome and Dravet syndrome. These syndromes are known to begin in childhood and persist in adulthood.

Epidiolex is made from purified cannabidiol (CBD), a compound present in the cannabis plant. CBD is known to have medicinal effects, however, it does not exert the mind-altering high that results from THC, the primary psychoactive component of marijuana.

"This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies," explains FDA Commissioner Scott Gottlieb.

A few states have approved CBD oil in the treatment of intractable epilepsy or seizure disorders.

A drug made from a derivative of marijuana has been approved for patients with certain forms of epilepsy. Blaine Harrington III/Getty Images

"Our biggest concerns with the artisanal [or supplement] versions of CBD were related to the consistency," Carson says. "We can't guarantee the consistency."

Carson believes he will likely prescribe Epidiolex in the future. "I'm always excited about the potential for a new therapy that has been well-studied and has a great potential for benefit," says Carson.

Multiple investigators are examining the efficacy of CBD in the treatment of psychiatric conditions. For example, a clinical study is now underway to examine whether CBD can effectively treat post-traumatic stress disorder and alcohol use disorder. Additionally, another clinical study will test whether CBD could be a potential treatment to help prevent relapse in opioid abusers.

Such approval of Epidiolex will help open the doors to more studies on CBD, which will lift a regulatory hurdle. As of now, the Drug Enforcement Administration placed CBD in the heroin and LSD category as a Schedule 1 substance which mean that these drugs have no medical use potential and only a high abuse substance.

According to Dr. Douglas Throckmorton, deputy director of regulatory programs at the FDA's Center for Drug Evaluation and Research , when CBD is approved as a medical use drug- the DEA will change its classification.

"The DEA will need to make a different scheduling decision for CBD...because it now has an accepted medical use," explains Throckmorton.

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 11, 2020
Cancer
APR 11, 2020
The Mice Make the Difference in CAR-T Studies
It is quite common in cancer therapies to see a drug or treatment that has been around for decades. New drugs are hard t ...
APR 20, 2020
Drug Discovery & Development
APR 20, 2020
First Successful Vaccine for Middle-East Respiratory Syndrome
Researchers have successfully completed the first-in-human clinical trial for a vaccine against MERS (Middle East Respir ...
APR 27, 2020
Cancer
APR 27, 2020
The Tumor Suppressor and its Regulator: An Indirect Oncogene
Oncogenes, mutations in genes that promote cancer growth, have long been easy targets for cancer research due to the dir ...
APR 30, 2020
Drug Discovery & Development
APR 30, 2020
Researchers Use AI to Accelerate COVID-19 Drug Development
Researchers from the National University of Singapore (NUS) have developed an artificial intelligence platform to accele ...
MAY 06, 2020
Drug Discovery & Development
MAY 06, 2020
Why Doctors are Repurposing Drugs to Treat COVID-19
Creating a drug from scratch is a lengthy process. Often taking years, given the rate of infection and deadliness of COV ...
MAY 13, 2020
Drug Discovery & Development
MAY 13, 2020
FDA Fast Tracks Vaccine for COVID-19
Biopharmaceutical company, Moderna, has announced that the US Food and Drug Administration has approved its experimental ...
Loading Comments...